Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04658771 · ClinicalTrials.gov registry record · Phase 2

MR-HIFU Treatment of Painful Osteoid Osteoma

A Phase 2 study of Osteoid Osteoma, sponsored by Children's National Research Institute.

Active
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT04658771 is a Phase 2 study of Osteoid Osteoma that is active but no longer recruiting, run by Children's National Research Institute. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04658771, a Phase 2 study of Osteoid Osteoma, is active but no longer recruiting, sponsored by Children's National Research Institute.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

To determine treatment safety and efficacy of MR-HIFU ablation of painful Osteoid Osteoma (OO) in children and young adults.

Conditions Studied

Interventions

  • DEVICE MR-HIFU treatment

Study Locations (1)

District of Columbia

  • Children's National Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-01-28
Est. Completion 2025-12-30
Phase Phase 2

What the Registry Record Tells You About NCT04658771

The ClinicalTrials.gov registry entry for NCT04658771 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoid Osteoma appearing as the primary indexed condition, and to 1 intervention - of which MR-HIFU treatment is the first listed.

NCT04658771 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT04658771 about?

NCT04658771 is a clinical study titled "MR-HIFU Treatment of Painful Osteoid Osteoma". To determine treatment safety and efficacy of MR-HIFU ablation of painful Osteoid Osteoma (OO) in children and young adults.

What is the current status of trial NCT04658771?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2021-01-28. Estimated completion is 2025-12-30.

What conditions does trial NCT04658771 study?

This clinical trial studies the following conditions: Osteoid Osteoma.

What interventions are being tested in trial NCT04658771?

The interventions under investigation include: MR-HIFU treatment (DEVICE).

Who is sponsoring clinical trial NCT04658771?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04658771 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoid Osteoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.